Literature DB >> 18431828

Anion gap, anion gap corrected for albumin, and base deficit fail to accurately diagnose clinically significant hyperlactatemia in critically ill patients.

Lakhmir S Chawla1, Dhiraj Jagasia, Lynn M Abell, Michael G Seneff, Melinda Egan, Natale Danino, Aline Nguyen, Mazer Ally, Paul L Kimmel, Christopher Junker.   

Abstract

Anion gap, anion gap corrected for serum albumin, and base deficit are often used as surrogates for measuring serum lactate. None of these surrogates is postulated to predict hyperlactatemia in the critically ill. We prospectively collected data from September 2004 through August 2005 for 1381 consecutive admissions. Patients with renal disease, ketoacidosis, or toxic ingestion were excluded. Anion gap, anion gap corrected for albumin, and base deficit were calculated for all patients. We identified 286 patients who met our inclusion or exclusion criteria. The receiver-operating characteristic area under the curve for the prediction of hyperlactatemia for anion gap, anion gap corrected for albumin, and base deficit were 0.55, 0.57, and 0.64, respectively. Anion gap, anion gap corrected for albumin, and base deficit do not predict the presence or absence of clinically significant hyperlactatemia. Serum lactate should be measured in all critically ill adults in whom hypoperfusion is suspected.

Entities:  

Mesh:

Year:  2008        PMID: 18431828     DOI: 10.1177/0885066607312985

Source DB:  PubMed          Journal:  J Intensive Care Med        ISSN: 0885-0666            Impact factor:   3.510


  8 in total

Review 1.  The serum anion gap in the evaluation of acid-base disorders: what are its limitations and can its effectiveness be improved?

Authors:  Jeffrey A Kraut; Glenn T Nagami
Journal:  Clin J Am Soc Nephrol       Date:  2013-07-05       Impact factor: 8.237

Review 2.  Etiology and therapeutic approach to elevated lactate levels.

Authors:  Lars W Andersen; Julie Mackenhauer; Jonathan C Roberts; Katherine M Berg; Michael N Cocchi; Michael W Donnino
Journal:  Mayo Clin Proc       Date:  2013-10       Impact factor: 7.616

3.  Utilization of base deficit and reliability of base deficit as a surrogate for serum lactate in the peri-operative setting.

Authors:  Lakhmir S Chawla; Amirali Nader; Todd Nelson; Trusha Govindji; Ryan Wilson; Sonia Szlyk; Aline Nguyen; Christopher Junker; Michael G Seneff
Journal:  BMC Anesthesiol       Date:  2010-09-09       Impact factor: 2.217

4.  Effect of the independent acid base variables on anion gap variation in cardiac surgical patients: a Stewart-Figge approach.

Authors:  Michalis Agrafiotis; Ilias Keklikoglou; Sofia Papoti; George Diminikos; Konstantinos Diplaris; Vassileios Michaelidis
Journal:  ScientificWorldJournal       Date:  2014-02-03

5.  Muscle oxygenation as an indicator of shock severity in patients with suspected severe sepsis or septic shock.

Authors:  Kenneth A Schenkman; David J Carlbom; Eileen M Bulger; Wayne A Ciesielski; Dana M Fisk; Kellie L Sheehan; Karin M Asplund; Jeremy M Shaver; Lorilee S L Arakaki
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

Review 6.  Diagnosis and management of metabolic acidosis: guidelines from a French expert panel.

Authors:  Boris Jung; Mikaël Martinez; Yann-Erick Claessens; Michaël Darmon; Kada Klouche; Alexandre Lautrette; Jacques Levraut; Eric Maury; Mathieu Oberlin; Nicolas Terzi; Damien Viglino; Youri Yordanov; Pierre-Géraud Claret; Naïke Bigé
Journal:  Ann Intensive Care       Date:  2019-08-15       Impact factor: 6.925

7.  Anion gap, anion gap corrected for albumin, base deficit and unmeasured anions in critically ill patients: implications on the assessment of metabolic acidosis and the diagnosis of hyperlactatemia.

Authors:  Lakhmir S Chawla; Shirley Shih; Danielle Davison; Christopher Junker; Michael G Seneff
Journal:  BMC Emerg Med       Date:  2008-12-16

8.  Base excess is superior to lactate-levels in prediction of ICU mortality after cardiac surgery.

Authors:  Bjoern Zante; Hermann Reichenspurner; Mathias Kubik; Stefan Kluge; Joerg C Schefold; Carmen A Pfortmueller
Journal:  PLoS One       Date:  2018-10-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.